Fig. 2: Imaging Response to Neoadjuvant Treatment. | Nature Communications

Fig. 2: Imaging Response to Neoadjuvant Treatment.

From: Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

Fig. 2

A Waterfall plot of radiographic responses to neoadjuvant treatment. The percent change in size of the largest lymph node from before to after neoadjuvant treatment is shown for all patients with measurable disease per RECIST 1.1 who completed adjuvant therapy on protocol and had post-neoadjuvant imaging assessment on protocol. B Comparison of Imaging and Pathologic Response.

Back to article page